Powerful anti‐inflammatory action of luteolin: Potential increase with IL‐38-Reference-Cited by-同舟云学术

Powerful anti‐inflammatory action of luteolin: Potential increase with IL‐38

Published:2021-03 Issue:2 Volume:47 Page:165-169
ISSN:0951-6433
Container-title:BioFactors
language:en
Short-container-title:BioFactors

Author:

Conti Pio¹^ORCID,Caraffa Alessandro²,Gallenga Carla E.³,Ross Rhiannon⁴,Kritas Spyros K.⁵,Frydas Ilyas⁶,Younes Alì⁷,Di Emidio Paolo⁸,Ronconi Gianpaolo⁹,Pandolfi Franco¹⁰

Affiliation:

1. Postgraduate Medical School University of Chieti Chieti Italy

2. School of Pharmacy University of Camerino Camerino Italy

3. Molecular Medicine, Department of Morphology, Surgery, Experimental Medicine University of Ferrara Ferrara Italy

4. Department of Veterinary Medicine University of Pennsylvania School of Veterinary Medicine Philadelphia Pennsylvania USA

5. Department of Microbiology University of Thessaloniki Thessaloniki Greece

6. Department of Parasitology, School of Veterinary Medicine University of Thessaloniki Thessaloniki Greece

7. Anesthesia Department Centro Medico Pescara Italy

8. Laboratory Medicine Maxillofacial Surgery Teramo Italy

9. Fondazione Policlinico Universitario A. Gemelli IRCCS Università Cattolica del Sacro Cuore Rome Italy

10. Department of Internal Medicine Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore Rome Italy

Publisher

Wiley

Subject

Clinical Biochemistry,Molecular Medicine,General Medicine,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/biof.1718

Reference43 articles.

1. Interleukin-1 and the Pathogenesis of the Acute-Phase Response

2. In vitro enhanced throboxane B2 release by polymorhonuclear leukocytes and macrophages after treatment with human recombinant interleukin 1

3. Chronic inflammation in the etiology of disease across the life span

4. IL-37 is increased in brains of children with autism spectrum disorder and inhibits human microglia stimulated by neurotensin

5. CAR‐T cell therapy causes inflammation by IL‐1 which activates inflammatory cytokine mast cells: anti‐inflammatory role of IL‐37;Caraffa A;J Biol Regul Homeost Agents,2019

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the mechanism of luteolin improving immune and inflammatory responses in systemic sclerosis based on systems biology and cell experiments;International Immunopharmacology;2024-09

2. The Search for Drugs Derived from Natural Products for Toxoplasma gondii Infection Treatment in the Last 20 Years - A Systematic Review;Current Topics in Medicinal Chemistry;2024-09

3. Progress, pharmacokinetics and future perspectives of luteolin modulating signaling pathways to exert anticancer effects: A review;Medicine;2024-08-23

4. Luteolin Mitigates D-Galactose-Induced Brain Ageing in Rats: SIRT1-Mediated Neuroprotection;Neurochemical Research;2024-07-11

5. Evaluation of the mechanism of Gong Ying San activity on dairy cows mastitis by network pharmacology and metabolomics analysis;PLOS ONE;2024-04-17